Dongfang Bio: Net profit loss of 163 million yuan in the first half of 2025.
Oriental Bio announced that its operating income in the first half of 2025 was 403 million yuan, a year-on-year decrease of 3.62%. The net profit attributable to the shareholders of the listed company was -163 million yuan, compared to -152 million yuan in the same period last year.
Latest